---
pmid: '27194766'
title: ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent
  Degradation Pathway.
authors:
- Xue B
- Yang D
- Wang J
- Xu Y
- Wang X
- Qin Y
- Tian R
- Chen S
- Xie Q
- Liu N
- Zhu H
journal: J Virol
year: '2016'
full_text_available: false
pmcid: PMC4944290
doi: 10.1128/JVI.00352-16
---

# ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway.
**Authors:** Xue B, Yang D, Wang J, Xu Y, Wang X, Qin Y, Tian R, Chen S, Xie Q, Liu N, Zhu H
**Journal:** J Virol (2016)
**DOI:** [10.1128/JVI.00352-16](https://doi.org/10.1128/JVI.00352-16)
**PMC:** [PMC4944290](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944290/)

## Abstract

1. J Virol. 2016 Jul 11;90(15):6832-45. doi: 10.1128/JVI.00352-16. Print 2016 Aug
 1.

ISG12a Restricts Hepatitis C Virus Infection through the 
Ubiquitination-Dependent Degradation Pathway.

Xue B(1), Yang D(1), Wang J(1), Xu Y(1), Wang X(2), Qin Y(1), Tian R(1), Chen 
S(1), Xie Q(1), Liu N(1), Zhu H(3).

Author information:
(1)Department of Molecular Medicine of College of Biology, State Key Laboratory 
of Chemo/Biosensing and Chemometrics, Hunan University, Changsha, China.
(2)Department of Molecular Medicine of College of Biology, State Key Laboratory 
of Chemo/Biosensing and Chemometrics, Hunan University, Changsha, China Research 
Center of Cancer Prevention and Treatment, Translational Medicine Research 
Center of Liver Cancer, Hunan Provincial Tumor Hospital (Affiliated Tumor 
Hospital of Xiangya Medical School of Central South University), Changsha, 
China.
(3)Department of Molecular Medicine of College of Biology, State Key Laboratory 
of Chemo/Biosensing and Chemometrics, Hunan University, Changsha, China Research 
Center of Cancer Prevention and Treatment, Translational Medicine Research 
Center of Liver Cancer, Hunan Provincial Tumor Hospital (Affiliated Tumor 
Hospital of Xiangya Medical School of Central South University), Changsha, China 
zhuhaizhen69@yahoo.com.

Interferons (IFNs) restrict various kinds of viral infection via induction of 
hundreds of IFN-stimulated genes (ISGs), while the functions of the majority of 
ISGs are broadly unclear. Here, we show that a high-IFN-inducible gene, ISG12a 
(also known as IFI27), exhibits a nonapoptotic antiviral effect on hepatitis C 
virus (HCV) infection. Viral NS5A protein is targeted specifically by ISG12a, 
which mediates NS5A degradation via a ubiquitination-dependent proteasomal 
pathway. K374R mutation in NS5A domain III abrogates ISG12a-induced 
ubiquitination and degradation of NS5A. S-phase kinase-associated protein 2 
(SKP2) is identified as an ubiquitin E3 ligase for NS5A. ISG12a functions as a 
crucial adaptor that promotes SKP2 to interact with and degrade viral protein. 
Moreover, the antiviral effect of ISG12a is dependent on the E3 ligase activity 
of SKP2. These findings uncover an intriguing mechanism by which ISG12a 
restricts viral infection and provide clues for understanding the actions of 
innate immunity.
IMPORTANCE: Upon virus invasion, IFNs induce numerous ISGs to control viral 
spread, while the functions of the majority of ISGs are broadly unclear. The 
present study shows a novel antiviral mechanism of ISGs and elucidated that 
ISG12a recruits an E3 ligase, SKP2, for ubiquitination and degradation of viral 
protein and restricts viral infection. These findings provide important insights 
into exploring the working principles of innate immunity.

Copyright Â© 2016, American Society for Microbiology. All Rights Reserved.

DOI: 10.1128/JVI.00352-16
PMCID: PMC4944290
PMID: 27194766 [Indexed for MEDLINE]
